biosimilars

FDA Rejects Alvotech’s Stelara Biosimilar as Manufacturing Problems Continue
BioSpace
Thu, 10/12/23 - 10:22 am
Alvotech
AVT04
JNJ
Stelara
biosimilars
FDA
FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
Generics Bulletin
Mon, 10/9/23 - 11:35 pm
Pfizer
Humira
biosimilars
adalimumab
AbbVie
interchangeability
FDA
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Wed, 10/4/23 - 11:21 am
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Boehringer launches 81% discounted biosimilar of AbbVie's Humira
Reuters
Mon, 10/2/23 - 06:34 pm
Boehringer Ingelheim
biosimilars
AbbVie
Humira
unbranded biosimilars
Biogen nabs FDA nod for biosimilar version of Roche's blockbuster Actemra
Fierce Pharma
Mon, 10/2/23 - 11:48 am
Biogen
Roche
Actemra
autoimmune disease
biosimilars
Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector
Fierce Pharma
Mon, 09/25/23 - 07:56 pm
Coherus Biosciences
Neulasta
biosimilars
FDA
Junshi Biosciences
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
BioSpace
Thu, 09/21/23 - 11:53 am
Alvotech
FDA
biosimilars
AVT02
AbbVie
Humira
Alvotech gets new FDA review for Humira biosimilar
BioPharma Dive
Wed, 09/20/23 - 11:07 pm
Alvotech
FDA
Humira
biosimilars
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Medical Marketing and Media
Wed, 09/20/23 - 08:41 am
PBMs
biosimilars
Humira
FDA revises biosimilar guidelines for clearer drug labelling
Pharmaceutical Technology
Mon, 09/18/23 - 07:50 pm
FDA
biosimilars
labeling
Sandoz to Commercialize Samsung Bioepis’ Biosimilar to J&J’s Stelara
BioSpace
Tue, 09/12/23 - 10:40 am
Sandoz
Samsung Bioepis
biosimilars
JNJ
Stelara
AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report
BioSpace
Fri, 09/8/23 - 11:29 am
AbbVie
Humira
biosimilars
Crohn's Disease
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
Motley Fool
Tue, 09/5/23 - 08:39 pm
Novartis
biosimilars
Eylea
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Tue, 09/5/23 - 11:18 am
Novartis
Sandoz
spinoffs
generics
biosimilars
FDA Approves Sandoz Biosimilar to Biogen’s MS Therapy Tysabri
BioSpace
Fri, 08/25/23 - 09:53 am
Biogen
Sandoz
FDA
biosimilars
MS
multiple sclerosis
Tysabri
CVS Health Enters Biosimilars Market with Launch of Cordavis Subsidiary
BioSpace
Thu, 08/24/23 - 10:23 am
CVS Health
biosimilars
Cordavis
Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Biopharma Reporter
Mon, 08/21/23 - 06:50 pm
Novartis
Sandoz
spinoff
biosimilars
generics
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Fri, 08/18/23 - 11:29 am
Novartis
Sandoz
spinoffs
generics
biosimilars
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration
What’s Next In Biologics? Biosimilar Expert Predicts Big Fall Changes
Forbes
Fri, 08/11/23 - 10:06 am
biologics
biosimilars
legislation

Pages